Purpose: To determine whether the levels of cytokines and chemokines in tears differ in uveitis patients and healthy subjects. Methods: Ninety-two uveitis patients (mean age 46.4 years) and 157 control healthy subjects (mean age 49.5 years) were recruited. Subjects with ocular surface diseases such as dry eye were excluded from the study. Using multiplex bead-based assays, tears (4 ll) were analysed for the concentration of interleukin (IL)-1b, IL-1RA, IL-2, IL-6, IL-7, IL-8/CXCL8, IL-10, IL-12p70, IL-15, IL-17A, IL-23, epidermal growth factor (EGF), fractalkine/CX3CL1, interferon-c, IP-10/ CXCL10, monocyte chemo-attractant protein (MCP)-1/CCL2, tumour necrosis factor-a, vascular endothelial growth factor (VEGF), transforming growth factor (TGF)-b1, TGF-b2 and TGF-b3. Tear molecule levels were compared between the groups and among the different forms of uveitis and disease severity. Results: Epidermal growth factor, IL-1RA, IL-7, IL-8/CXCL8, IP-10/ CXCL10, MCP-1/CCL2, TGF-b2 and VEGF were detected in more than 75% of the samples in both groups. Statistically significant differences in percentage of detection between control and patient groups were found for IL-23, IL-1b, IL-15, EGF, fractalkine/CX3CL1 and MCP-1/CCL2. The concentrations of IL-1RA, IL-8/CXCL8, fractalkine/CX3CL1, IP-10/CXCL10, VEGF and TGF-b2 in uveitis tear samples were elevated compared to controls (p < 0.05). Significant differences in tear levels of those molecules and also EGF were also present depending on the anatomic classification of uveitis. Conclusion: There were significant differences in the levels of several cytokines and chemokines in tears of patients with uveitis compared with healthy subjects. These results can help understand the underlying pathophysiology of the uveitis and could potentially aid in diagnosis.
Introduction
The term 'uveitis' refers mainly to inflammation of the uvea or choroid, although adjacent structures such as the retina, vitreous, sclera or cornea are frequently involved. Intraocular inflammatory diseases constitute an important problem, which due to the frequency and severity, represent the fourth largest cause of legal blindness in patients between 20 and 60 years of age (Durrani et al. 2004) . Uveitis can be classified according to the anatomic location or to aetiology. Anatomically, uveitis is divided into four categories: anterior uveitis, intermediate uveitis, posterior uveitis and panuveitis (Jabs et al. 2005) . According to the aetiology, it can be classified as infectious, traumatic, neoplastic or autoimmune (Jabs et al. 2005) .
Uveitis is frequently chronic in nature and is difficult to manage, which often confers long-term treatments and the presence of severe associated side-effects (Gallant & Kenny 1986) . Despite new strategies of treatment, the incidence of visual impairment and blindness secondary to uveitis has not significantly decreased in the last 30 years (Foster & Vitale 2002 ). An early diagnosis is warranted to minimize complications and provide prompt and adequate treatment. However, difficulty in diagnosis can delay the treatment in some cases.
It is well established that cytokines and chemokines play a major role in the pathogenesis and persistence of intraocular inflammation. Different studies have demonstrated increases of cytokines and chemokines in serum, aqueous humour and vitreous samples from patients suffering from uveitis (Curnow & Murray 2006; Ooi et al. 2006; Lahmar et al. 2009; El-Asrar et al. 2011; Kuiper et al. 2011; Valentincic et al. 2011; Abu El-Asrar et al. 2012; Ang et al. 2012; Nagata et al. 2012) . These studies attempted to determine whether there were correlations between the levels of these molecules with the clinical phenotypes and to identify any specific factors involved in each type of uveitis or which may contribute to it. However, the collection of aqueous and vitreous samples from patients carries important risks such as endophthalmitis, retinal detachment and intraocular haemorrhage. Thus, collection of aqueous or vitreous samples is not routinely performed unless the diagnosis is in question, especially if infectious causes are being considered.
The conjunctival involvement in uveitis has not been extensively studied, and although conjunctival injection is often present in anterior uveitis (Nussenblatt & Whitcup 2004) , little is known about ocular surface inflammation in patients with uveitis. In an experimental model of uveitis that analysed the presence of chemokines and chemokine receptors in the conjunctival epithelium and stroma, the ocular surface mimicked the intraocular inflammatory pathways (Trinh et al. 2008) . It has been suggested that the tears could be used to monitor the in vivo state of the ocular surface (Leonardi et al. 1999 ). Tear samples, unlike aqueous humour or vitreous samples, are easy to collect by a non-invasive, painless procedure that can be performed in the office. Changes in the levels of several cytokines and chemokines in tears from patients suffering from several ocular surface diseases such as allergies, rosacea and dry eye syndrome have already been reported (Barton et al. 1997 (Barton et al. , 1998 Lema & Duran 2005; Leonardi et al. 2006; Sack et al. 2007; Lam et al. 2009; Enriquez-de-Salamanca et al. 2010; Lopez-Miguel et al. 2014) . However, to our knowledge, there are no studies reporting the levels of cytokines/chemokines in tears from patients with uveitis. Thus, the aim of this pilot study was to determine whether there are differences in the cytokine/chemokine levels in tears of uveitis patients in either the active or inactive states compared to healthy volunteers.
Patients and Methods

Patients and clinical evaluation
This study was approved by the Institutional Review Boards of the Institute of Applied OphthalmoBiology (IOBA) and University Clinic Hospital (Valladolid, Spain) and by the University Ethics Committee. Study participants were selected among patients with uveitis at the Ocular Immunology and Uveitis Unit of both IOBA and University Clinic Hospital. Informed consent was obtained from each participant over 18 years old, and parental consent was provided in the case of patients under that age. The study was conducted in accordance with the tenets of the Declaration of Helsinki.
Eligible patients had a clinical diagnosis of uveitis (anterior, intermediate, posterior and panuveitis), but could be either active or inactive. Exclusion criteria were the presence of any other active ocular surface disease at the time of sample collection, such as infectious conjunctivitis, keratitis, allergy or dry eye disease.
A group of healthy subjects was selected as controls. Exclusion criteria included systemic disease, pregnancy or nursing, any medication use (either systemic or topical, including artificial tears), a previous history of any ophthalmic disease (including ocular surface diseases such as dry eye or ocular allergies) and any ocular symptoms. Contact lens wearers were also excluded.
Both patients and healthy individuals were examined under slit lamp to verify the presence of a normal ocular surface and to rule out any concomitant ocular surface disease, such as blepharitis, dry eye, active keratitis or conjunctivitis.
The type of uveitis, anatomic classification and grade of inflammation was defined according to the criteria proposed by the Standarization of Uveitis Nomenclature (SUN) working group (Jabs et al. 2005) . Additionally, the different uveitis aetiologies were further grouped as either non-infectious or infectious uveitis according to the presumed specific aetiology of each case (Table 1) .
Tear sample collection
Single tear samples were obtained from each eye and were maintained separately, without pooling. For healthy subjects, only one randomly chosen eye was included in the study. In the case of bilateral uveitis, both eyes were sampled. If the uveitis was strictly unilateral, samples were collected from the affected eye and also from the contralateral healthy eye whenever possible. Tear samples (4 ll) were obtained prior to or at least 60 min after the instillation of vital dyes such as fluorescein. Tears were collected non-traumatically with a 4-ll calibrated capillary tube (Drummond, Broomall, PA, USA) from the lateral canthus so as to avoid reflex tearing as much as possible. The collected samples were placed separately into sterile collection tubes containing 16 ll of ice-cold Cytokine Assay Buffer (HCYTO60-K Milliplex, Millipore, Merck Chemicals and Life Science S.A. Madrid, Spain). The tubes were kept cold during collection and stored at À80°C until assayed.
Analysis of cytokine/chemokine tear concentration
Cytokine and chemokine levels in the tear samples were determined by multiplex bead analysis in a Luminex IS-100 instrument (Luminex Corporation, Austin, TX, USA). The concentrations of a total of 21 molecules were measured in three separate assays. Interleukin (IL)-1b, IL-1RA, IL-2, IL-6, IL-7, IL-8/CXCL8, IL-10, IL-12p70, IL-15, IL-17A, epidermal growth factor (EGF), fractalkine/CX3CL1, interferon (IFN)-c, IFN-c-induced protein (IP)-10/CXCL10, monocyte chemoattractant protein (MCP)-1/CCL2, tumour necrosis factor (TNF)-a and vascular endothelial growth factor (VEGF) were measured simultaneously in a 17-plex assay (Milliplex HCY-TO60K-17X, Millipore). IL-23 was assayed alone (Milliplex MPXHCYP2 -62K-1X, Millipore). Transforming growth factor (TGF)-b1, TGF-b2 and TGF-b3 isoforms were measured with a 3-plex assay (Milliplex TGFB-64K-03, Millipore).
The samples were assayed following the manufacturer's protocols with some modifications for low volume assays. Briefly, 10 ll of a final 1:10 diluted tear sample (1:5 dilution at collection and posterior dilution 1:2 before assay) was incubated with antibody-coated capture beads for 2 hr at 20°C. For the TGF-b isoforms, the samples were previously acidified with HCl for 1 hr and thereafter neutralized with NaOH for the release of latent TGF-b. After the 2-hr incubation, the beads were washed with buffer and then incubated with biotin-labelled anti-human cytokine/chemokine antibodies or anti-human TGF-b for 1 hr. This was followed by incubation with streptavidin-phycoerythrin for 30 min. Then, samples were resuspended in assay buffer and analysed in the Luminex IS-100. Standard curves with known concentrations of recombinant human cytokines and chemokines and with TGF-b1, TGF-b2 and TGF-b3 were used to convert fluorescence units to concentrations (pg/ml). The collected data were stored and analysed using the 'BEAD VIEW Software' (Upstate-Millipore, Watford, UK). The minimum detectable concentrations (provided by the assay manufacturer) were (in pg/ml) IL-15 = 0.1; IL-17A = 0.25; IL-2 = 0.3; IL-1b, IL-3 and IL-8/CXCL8 = 0.4; IL-10 = 0.7; IL-12p70 = 0.8; TNF-a, IFN-c and IL-6 = 1.1; IP-10/CXCL10 = 1.14; IL-7 = 1.2; VEGF = 2.6; MCP-1/CCL2 = 3.0; fractalkine/CX3CL1 = 4.27; TGFb2 and TGF-b3 = 6; IL-1R = 10.97; TGF-b1 = 12; IL-23 = 28.6. The percentage of detection of each molecule in each group was calculated. For statistical analysis, in cases where the assayed molecule was undetectable, we assigned it the minimum detectable value of the assay; however, molecules that were detected in <60% of the samples in both groups were not further statistically compared.
Statistical analysis
The data were expressed as means AE standard error of the mean (SEM) unless otherwise specified. The cytokine/chemokine tear percentage of detection and the tear levels were compared among the different groups as follow: uveitis (active and inactive; anterior, intermediate, posterior and panuveitis; infectious and non-infectious) patients, healthy controls and contralateral healthy eye in the cases of unilateral uveitis. To assess the difference in the percentage of detection between groups, the equality of proportions test was used and 95% confidence intervals were calculated for each percentage. The distribution normality of each variable was assessed by the Kolmogorov-Smirnov test. For variables not having a normal distribution, the differences between the levels of cytokines/chemokines in the different groups were analysed with the MannWhitney nonparametric U-test in case of two independent samples and by Kruskal-Wallis test for independent samples in the case of more than two samples with the 'post hoc' Dunn's test. In cases where the samples were obtained from both eyes of the same patient, the nonparametric test of Wilcoxon for related samples was used. p-values of ≤0.05 were considered statistically significant, with the Bonferroni correction for the cases where there were multiple comparisons.
Results
Clinical data
Eighty-five uveitis patients (50 females (58.8%), 35 males (41.2%); age 48.8 AE 18.2 years; range 11-87 years) and 157 healthy subjects (79 females (50.3%) and 78 males (49.7%); age 46.3 AE 17.7 years; range 17-88 years) were included in the study. There were no significant differences in the gender and age distribution between the two groups.
A total of 316 tear samples were collected. Of these, 159 samples were from uveitis patients, including 139 from eyes with uveitis and 20 from the contralateral eye (age: 45.5 AE 14.7 years; range 23-67) in cases of unilateral uveitis (Table 1) . Among the 20 contralateral eye samples, six were from eyes with active disease and 14 were from Seventy samples were from patients not receiving any systemic treatment at the time of sample collection, seven samples from patients only non-steroidal anti-inflammatory drugs, 39 samples from patients on one immunomodulatory agent (eight of them in combination with systemic steroids) and the combination of two or more immunomodulatory treatment in five samples, eight were on an anti-TNF-a agent (plus 1 or 2 classical immunomodulatory agents in six cases), 11 samples from patients only taking systemic steroids and 19 from patients that were on treatment with systemic antibiotics or antivirals for infectious uveitis.
Cytokine/chemokine percentages of detection Out of the 21 molecules measured, the following eight were detected in more than 75% of the samples in the patient and control groups (Table 2) : MCP-1/ CCL2, EGF, TGF-b2, IL-1RA, IL-8/ CXCL8, IP-10/CXCL10, IL-7 and VEGF. Fractalkine/CX3CL1 was detected in 94% of the control samples and in 66% of the uveitis samples. The rest of the assayed molecules had percentages of detection within the 0.6-39.6% range. For eight molecules, there were significant differences in the percentage of detection between control and uveitis patients group: IL-23 was detected at a significantly higher rate in the uveitis group compared to the control group. In contrast, IL-1b, IL-7, IL-15, EGF, fractalkine/CX3CL1, MCP-1/ CCL2 and TGF-b1 were detected at significantly lower rates in the uveitis group compared to the control group.
IL-1b, IL-2, IL-6, IL-10, IL-12p70, IL-15, IL-17A, IL-23, IFN-c, TNF-a, TGF-b1 and TGF-b3 were not further considered for the statistical analysis of concentrations due to their low percentage of detection (<60% in all the cases).
Therefore, only the levels of nine molecules were used for the further comparisons, and the Bonferroni correction was applied for nine comparisons; consequently, a level of p ≤ 0.005 was considered as statistically significant.
Cytokine/chemokine tear levels uveitis versus controls
Uveitis (active + inactive) versus controls
The tear concentrations of IL-1RA (p < 0.001), IL-8/CXCL8 (p < 0.001), fractalkine/CX3CL1 (p = 0.002), IP-10/ CXCL10 (p = 0.001), VEGF (p < 0.001) and TGF-b2 (p < 0.001) were significantly higher in uveitis patients than in healthy controls (Table 3 , Fig. 1 ).
Cytokine/chemokine tear levels compared by uveitic activity There were differences in the concentration of IL-1RA (p < 0.001), IL-8/ CXCL8 (p < 0.001), IP-10/CXCL10 (p < 0.001), VEGF (p < 0.001) and TGF-b2 (p < 0.001) according to the uveitic activity, in particular:
Active uveitis versus inactive uveitis
There were no significant differences between the active uveitis and inactive uveitis regarding the concentration of any cytokine/chemokine assayed.
Active uveitis versus controls
The levels of VEGF (p = 0.014) and TGF-b2 (p < 0.001) in the tears of uveitis patients were significantly higher than in the controls (Fig. 2) .
Inactive uveitis versus controls
Similar to the total uveitis (active + inactive) group, the levels of IL-1RA (p < 0.001), IL-8/CXCL8 (p = 0.002), IP-10/CXCL10 (p = 0.011), VEGF (p = 0.001) and TGF-b2 (p < 0.001) were greater in the inactive uveitis patients compared to the controls (Fig. 2) . n = sample size; % = percentage of detection; CI (95%) = confidence interval at 95%. FRACT = fractalkine; NS = not significant. Statistically significant differences between control and uveitis groups are highlighted in bold. The molecules that were detected in at least 60% of the samples are denoted with dark grey pattern.
Active uveitis versus contralateral eyes
There was no difference in the levels of cytokines and chemokines between active uveitis and contralateral eyes in the non-paired samples (Fig. 2) .
Similarly, when the statistical analysis was performed using paired comparisons, then there were no significant differences in the levels of tear cytokine/chemokines (data not shown).
Inactive uveitis versus contralateral eyes
There was no difference in the levels of cytokines and chemokines between inactive uveitis and contralateral eyes (Fig. 2) . Similarly, when the statistical analysis was performed with samples comparing the 14 cases of inactive samples with the tears from the corresponding contralateral eyes, there were no statistically significant differences between the two groups.
Control versus contralateral, non-uveitic eyes
Interestingly, tear levels of IL-1RA (p = 0.006), IL-8/CXCL8 (p < 0.001), IP-10/CXCL10 (p = 0.002), VEGF (p < 0.001) and TGF-b2 (p = 0.001) were significantly higher in the contralateral, non-uveitic eyes of uveitis patients than in those of control healthy subjects (Fig. 2) .
Cytokine/chemokine tear levels compared by anatomic and aetiological classification
There were significant differences in tear cytokine/chemokine levels when comparisons were made by anatomic classification, that is anterior, intermediate, posterior and panuveitis (Fig. 3 ). There was a difference in the levels of IL-1RA (p < 0.001), IL-8/CXCL8 (p < 0.001), EGF (p = 0.004), fractalkine/CX3CL1 (p = 0.002), IP-10/CXCL10 (p < 0.001), VEGF (p < 0.001) and TGF-b2 (p < 0.001) according to the anatomic classification, with a high concentration of those mainly in the case of anterior uveitis and panuveitis (Fig. 3 ). In patients with anterior uveitis, the levels of IL-1RA (p < 0.001), IL-8/CXCL8 (p = 0.005), IP-10/CXCL10 (p = 0.003), VEGF (p = 0.006) and TGF-b2 (p < 0.001) were increased compared to healthy control tears. Similarly, the levels of IL-8/CXCL8 (p = 0.015) and IP-10/CXCL10 (p < 0.001) were also elevated in tears of anterior uveitis patients in comparison with posterior uveitis, and EGF in comparison with intermediate (p = 0.009) and panuveitis (p = 0.005). Likewise, in the panuveitis group, there was a statistically significant increase in the levels of IL-1RA (p = 0.002), IL-8/CXCL8 (p = 0.030), fractalkine/CX3CL1 (p = 0.004), IP-10/CXCL10 (p = 0.008), VEGF (p < 0.001) and TGF-b2 (p < 0.001) with respect to control, and in IP-10/ CXCL10 (p < 0.001) in comparison with posterior uveitis. In intermediate uveitis, the tear concentrations of IL- <0.001 NS = not significant. Statistically significant differences between uveitis and control groups are highlighted in bold. To compare cytokine/chemokine tear levels on the basis of the uveitis aetiology, we classified all of the cases as either infectious or non-infectious due to the low number of each of the specific uveitis aetiologies. IL-1RA (p < 0.001), IL-8/CXCL8 (p < 0.001), IP-10/CXCL10 (p = 0.001), VEGF (p < 0.001) and TGF-b2 (p < 0.001) had a statistically significant difference in the distribution among groups. In particular, there was an increase in IL-1RA levels in infectious (p < 0.001) and non-infectious uveitis (p < 0.001) in comparison with control; similarly, in the case of IL-8/CXCL8, there was an increase in infectious (p = 0.001) and non-infectious uveitis (p = 0.011) in comparison with control; for IP-10/ CXCL10, there was an increase in infectious (p = 0.003) and non-infectious uveitis (p = 0.046) in comparison with control; there was an increase in VEGF in infectious (p = 0.017) and non-infectious (p < 0.000) uveitis in comparison with control; TGF-b2 was increased in infectious (p < 0.001) and non-infectious uveitis (p < 0.001) in comparison with control. No significant differences between infectious and non-infectious uveitis were found (Fig. 4) .
Discussion
In this study, we described differences in the concentrations of cytokines and chemokines in tears of patients suffering from uveitis and healthy controls. Understanding the different patterns of concentrations of these molecules in tears can help determine the basis for future diagnostic tests for uveitis, and they can also help to understand the pathophysiology of this complex disease.
Cytokines and chemokines play an integral role in the co-ordination and persistence of inflammatory processes, and several studies have already shown that some cytokines and chemokines are increased in serum and in the aqueous and vitreous humours of uveitis patients (Curnow & Murray 2006; Ooi et al. 2006; Lahmar et al. 2009; El-Asrar et al. 2011; Kuiper et al. 2011; Valentincic et al. 2011; Abu El-Asrar et al. 2012; Ang et al. 2012; Nagata et al. 2012) . The concentrations of several cytokines and chemokines are also increased in tears of patients with ocular surface chronic inflammatory diseases such as dry eye disease, ocular allergy and others (Barton et al. 1997 (Barton et al. , 1998 Lema & Duran 2005; Leonardi et al. 2006; Sack et al. 2007; Lam et al. 2009; Enriquez-deSalamanca et al. 2010; Lopez-Miguel et al. 2014) . However, to our knowledge, there are not any studies that assess the tear cytokine/chemokine levels in uveitis patients. In the study reported here, the concentration of a panel of 21 inflammatory molecules was analysed in tears of uveitis patients and compared to healthy controls.
According to our results, there are significant differences between the tear cytokine/chemokine pattern of patients suffering from uveitis and normal controls. Uveitis patients had significantly increased tear levels of IL-1RA, IL-8/ CXCL8, fractalkine/CX3CL1, IP-10/ CXCL10, VEGF and TGF-b2 compared to the tears of healthy subjects. This finding held true for both infectious and non-infectious uveitis cases.
The majority of these molecules have already been associated with uveitis in other studies that measured them in serum, aqueous humour or vitreous samples (Curnow & Murray 2006; Ooi et al. 2006; Lahmar et al. 2009; El-Asrar et al. 2011; Kuiper et al. 2011; Valentincic et al. 2011; Abu El-Asrar et al. 2012; Ang et al. 2012; Nagata et al. 2012 ). The IL-1 receptor antagonist IL-1RA is a naturally occurring inhibitor of IL-1 activity, which has been implicated in the mediation of autoimmune diseases including uveitis (Dinarello & Wolff 1993; El-Shabrawi et al. 2000; Foxman et al. 2002) . There are a few reports of the use of anakinra, IL-1RA, on the treatment of uveitis (Arostegui et al. 2007; Teoh et al. 2007 ). The increased levels of IL-1RA detected in uveitis could indicate an attempt of the immune system to suppress the inflammation. Increased levels of IL-8/ CXCL8 have been described in the aqueous humour of idiopathic uveitis, sarcoidosis and Behc ßet (Ooi et al. 2006) . In endotoxin-induced uveitis models, there is an increase in fractalkine/CX3CL1 in aqueous humour (Chu et al. 2009) , which is consistent with the findings in our study of tears.
IP-10/CXCL10, which has antiangiogenic activity (Proost et al. 2001) , was found to be elevated in the vitreous of patient with sarcoidosis (Nagata et al. 2012) . IP-10/CXCL10 is a chemotactic molecule that is secreted by several cell types in response to IFN-c and that attracts T-lymphocytes, natural killer cells and monocytes. IP-10/CXCL10 and its receptor, CXCR3, appear to contribute to the pathogenesis of many autoimmune diseases, organ specific or systemic (Antonelli et al. 2014) . Increased expression of this molecule also occurs in some human chronic inflammatory diseases, as in the airways of subjects with chronic obstructive pulmonary disease (Saetta et al. 2002) and in patients with asthma (Miotto et al. 2001; Liu et al. 2004) , where the level is correlated with lymphocyte number. Chemokines that preferentially attract Th1 cells via the CXCR3 receptors, such as IP-10/CXCL10 or MIG/ CXCL9, are involved in the polarization of T-cell recruitment as they concomitantly block the migration of Th2 cells in response to CCR3 ligands (Loetscher et al. 2001 ). This chemokine can act to counter the effects of VEGF, which was also increased in the uveitis tear samples. In fact, anti-VEGF drugs have already proven to be effective on the treatment of uveitic macular oedema and in inflammatory choroidal neovascularization (Battaglia Parodi et al. 2010; Ossewaarde-van Norel & Rothova 2011) . IP-10/CXCL10 has also been involved in the pathogenesis of ocular Behcet's disease (Ambrose et al. 2015) .
In this study, TGF-b2 was significantly increased in tears from patients with uveitis. In the eye, TGF-b is present at high levels in the aqueous humour and is thought to be implicated in the maintenance of immune privilege (Cousins et al. 1991) . TGF-b2 levels are increased in experimental autoimmune uveitis and are thought to be antagonized by IL-6, such that TGF-b2 suppresses inflammation once IL-6 levels fall (Ohta et al. 2000) . TGFb2, in conjunction with a-melanocytestimulating hormone, generates ocular autoantigen-specific T regulatory cells that produce TGF-b1 and are able to reduce the incidence and severity of experimental autoimmune uveitis (Namba et al. 2002) .
Interestingly, we found no differences in cytokine tear levels between tears obtained from active and inactive uveitis cases. The lack of differences in the patterns of cytokines/chemokines in patients with active and inactive uveitis could be a sign of underdiagnosis of the inflammation in patients with uveitis. In such cases, a patient with uveitis could be classified as inactive based on only the clinical examinations despite the presence of a subclinical active intraocular inflammation. In fact, some authors have already proposed that it is not possible to determine the inflammatory state just by clinical examinations, advising the use of different technologies such as laser flare photometry to determine subclinical alterations in the blood-ocular barrier (Tugal-Tutkun & Herbort 2010) .
Tear samples from contralateral eyes also showed increased levels of several cytokines compared to the control group. The profile of molecules was very similar to that found increased in the uveitis samples. This again could be a sign of underdiagnosis in the clinically quiet eyes.
Significant differences in some molecules were also found in the contralateral tear samples when compared to the total active and inactive uveitis groups. However, no significant differences were found in these cases if comparisons were restricted to the corresponding uveitis-related eye. Because there were only six active and 14 inactive cases, the absence of significant differences in tear samples between the uveitic and non-uveitic contralateral paired eyes could be a consequence of the small number of samples analysed. The similarities in cytokine and chemokine levels in the tears of the contralateral eye in comparison with active or inactive uveitis could also indicate a systemic increase in the cytokines/ chemokines. A systemic increase would alter tear levels not only in the uveitis eye but also in the contralateral eye. This also raises the question of where these cytokines/chemokines in tears from uveitis patients are coming from. One possibility could be that they have been secreted by intraocular inflammatory cells and then percolated through the cornea from the anterior chamber. Another option could be that they have been secreted by epithelial and/or other cell types on the ocular surface, that could be inflamed, triggered from the intracellular inflammation. Furthermore, it could be that it is the reflex in tears of the systemic immune response and the cytokines/chemokines are filtered from serum to tear, which could justify the lack of differences in tear of the contralateral eye. Moreover, all of the uveitis patients were examined by slit lamp biomicroscopy to exclude the presence of keratitis or conjunctivitis that could result from ocular surface alterations, such as dry eye syndrome or allergy, and simultaneously alter the levels of tear cytokines and chemokines. Also, we were aware that uveitis patients are usually treated with a variety of topical drugs that could alter the ocular surface; however, the pattern of cytokine/chemokine increase was quite different in this study in comparison with that previously reported for glaucoma patients chronically treated with topical drops (Malvitte et al. 2007; Chong et al. 2010) . In those patients, there were increased levels of IL-2, IL-5, IL-10, IL-6, IL-12, MCP-1/CCL2 and TNF-a (Malvitte et al. 2007; Chong et al. 2010) , while none of these molecules was increased in the tears of our uveitis patients. Similarly, for dry eye disease, there is a different pattern of increased cytokines/chemokines in which the levels of IL-2, IL-5, IL-6, IL-8/CXCL8, IL-10, VEGF and TNF-a become elevated (Massingale et al. 2009; Enriquez-de-Salamanca et al. 2010) . Among those cytokines/ chemokines, only IL-8/CXCL8 and VEGF were significantly elevated in the tears of our uveitic patients.
For several of the studied molecules, that is IL-1RA, IL-8/CXCL8, EGF, fractalkine/CX3CL1, IP-10/CXCL10, VEGF and TGF-b2, differences in tear levels occurred depending on the anatomic classification of the uveitis. As one might expect, anterior and panuveitis samples had the highest concentrations of cytokines and chemokines. This could be the result of higher secretion of these molecules into the tears in cases where there was an inflammation in the anterior chamber. Inflammation of the anterior chamber could spread locally to the ocular surface, and therefore, the secretion of these molecules will be higher in comparison with intermediate or posterior uveitis. Additionally, there were changes in the tear levels of some molecules in intermediate and posterior uveitis.
In our study, some molecules were detected in <60% of the samples. Due to the low percentage of detection (<60% in all cases), they were not further considered for comparison because of the unreliability of the statistical analysis. These molecules included IL-1b, IL-2, IL-6, IL-12p70, IL-15, IL-17A, IL-23, IFN-c, TNF-a, TGF-b1 and TGF-b3. Among them, both IL-17 and IL-23 pathways have been described to be involved in uveitis, and both molecules have been reported to be increased in the aqueous humour of patients with birdshot chorioretinopathy (Kuiper et al. 2011 ) and Vogt-Koyanagi-Harada syndrome . They have also been suggested as novel therapeutic targets for the treatment of intraocular inflammatory diseases (Ke et al. 2009; Zhang et al. 2009 ). However, the levels of IL-17A have been already reported to be undetected in aqueous fluid of patient with Behc ßet's disease (Jiang et al. 2011) and similarly not detected or detected in a low concentration (26.6-81.3 pg/ml) in the case of tear samples from healthy controls (LaFrance et al. 2008; Carreno et al. 2010) . It is possible that the low detection rate of IL-17A in our samples could be related with a low concentration in tears below the level of detection of our assay. Similarly, there was a low detection of TNF-a in our samples. TNF-a plays an important role in the pathogenesis of non-infectious uveitis (Sharma et al. 2009 ). In fact, increased levels of TNF-a and its receptor have been found in the serum of patients with uveitis (Rodrigues et al. 2009 ). Blockage of this molecule with different anti-TNF-a drugs is an effective treatment in non-infectious uveitis that is refractory to other therapeutic approaches (Cordero-Coma et al. 2013; Lerman et al. 2013; Simonini et al. 2013; Suhler et al. 2013) . Although the levels of TNF-a have been found to be elevated in aqueous humour in different uveitis entities in comparison with control (Sijssens et al. 2007; Kuiper et al. 2011; Abu El-Asrar et al. 2012) , this has been in a low concentration, and therefore, it is possible that the tear concentration of TNF-a was below the level of detection of our assay. Also, its low levels could be related to the fact that some patients were under systemic treatment including anti-TNF-a agents, which could have affected the levels.
The study has some limitations, as there could be uncontrolled bias in patient selection between uveitis patients and controls, although we do not expect this effect would be too big, as they all belong to the same demographic condition and there were not significant differences neither in gender nor age between both groups. Also, multiple cytokines were analysed which increases the chance of type 1 error; however, the p-value was updated according to the Bonferroni correction to minimize this effect. These data are interesting, but additional studies to confirm these findings are warranted.
In summary, we report that the tears from patients with uveitis have a different profile of cytokine/chemokine concentrations in comparison with normal subjects. Further, there are some specific differences in the profile of cytokine/ chemokine expression that depends on the anatomic localization and the infectious/non-infectious aetiology.
Cytokines and chemokines orchestrate immune responses and are intrinsically linked to disease activity. Thus, based on these results, the ocular surface could mimic the inflammatory pathways of the intraocular inflammation, as proposed by others (Trinh et al. 2008) . It remains to be determined if the patterns of cytokines/chemokines found in tears are a reflection of the patterns of cytokines/chemokines expressed in aqueous or vitreous from patients with uveitis and how the interaction of these mediators in tears could relate to intraocular mechanisms of different types/aetiologies of uveitis. The design of this study does not allow to make any assumption regarding that matter; however, it could set the basis of further studies with paired samples of tears and aqueous or vitreous. If so, tear cytokine/chemokine analysis in these patients would provide a new way with easier access to the study of uveitis. Similarly, further studies could determine if the pattern of cytokines/chemokines in tears is diagnostic of specific aetiologies. If so, this could be an easy and effective tool to monitor the activity and aetiology in uveitis care. Also, the understanding of the patterns of cytokine/chemokine levels could be used to develop the basis of future treatments against specific targets.
